Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. - Baiyunshan Hanfang
You are now at:Blog > Article Content

Guangzhou Hanfang Pharmaceutical Chinas Trusted USP Grade Egg Yolk Lecithin Source Manufacturer

Time:2026-07-31

Globally Certified, Domestically Produced Excipient Breaks International Supply Monopolies

Guangzhou, China – 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients, health products, and technical services, today solidifies its role as a reliable source manufacturer of USP grade egg yolk lecithin in China. Developed to address the core pain point of unstable domestic supply for injectable excipients among pharmaceutical enterprises, this product leverages proprietary green extraction technology to break long-term international monopolies, achieving a leap in domestic localization rate from 10% to 90%. The company’s USP grade egg yolk lecithin is now available globally, serving over 1,000 clients across more than 30 countries and regions .

Core Technological Breakthroughs & Product Advantages

The USP grade egg yolk lecithin from Guangzhou Hanfang Pharmaceutical features a proprietary integrated green technology combining supercritical CO₂ extraction, membrane separation, and chromatographic separation, replacing traditional polluting processes to ensure product purity and environmental sustainability. This innovative technology has secured over 240 national patents, establishing a robust technical barrier in the industry .

As a key injectable excipient, the product serves as an emulsifier, solubilizer, and liposome membrane material, meeting the strict requirements of pharmaceutical enterprises producing injectable emulsions and liposome formulations, as well as research institutions engaged in lipid-based drug development .

Global Compliance & Certifications

To meet global market access standards, Guangzhou Hanfang Pharmaceutical’s USP grade egg yolk lecithin has obtained multiple international certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. The company also holds top-tier national qualifications, such as the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation (the only national-level engineering research center in the pharmaceutical lipid sector) and the Guangdong Provincial Key Laboratory of Pharmaceutical Lipids, alongside being recognized as a 2024 National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise .

Supply & Customization Services

The USP grade egg yolk lecithin is now available for global orders through the company’s official website and authorized distributors, with mass production and worldwide delivery already underway. In addition to standard products, Guangzhou Hanfang Pharmaceutical offers customized processing services tailored to the specific needs of pharmaceutical enterprises and research institutions, ensuring flexible solutions for diverse formulation requirements .

Authoritative Quote

"Our USP grade egg yolk lecithin represents a significant milestone in breaking international monopolies in high-end pharmaceutical excipients, ensuring stable and reliable domestic supply while adhering to global quality standards," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "This achievement aligns with our mission to achieve technological self-reliance, address 'bottleneck' challenges, and safeguard the security of the global pharmaceutical industry chain" .

Industry Context & Corporate Strategy

Historically, high-end pharmaceutical lipid excipients like USP grade egg yolk lecithin relied heavily on imports, creating supply chain vulnerabilities for global pharmaceutical enterprises. Guangzhou Hanfang Pharmaceutical’s localized production not only fills a domestic gap but also provides a trusted alternative for international clients seeking diversified supply sources .

Future Plans

Looking ahead, Guangzhou Hanfang Pharmaceutical will continue to focus on the R&D and innovation of pharmaceutical lipid excipients, increasing investment in green manufacturing technologies and expanding its global distribution network. The company aims to launch more compliant, high-quality products to meet evolving market demands, further strengthening its position as a global leader in the pharmaceutical excipient sector .

About Guangzhou Hanfang Pharmaceutical Company Limited

Founded in 1998, Guangzhou Hanfang Pharmaceutical Company Limited is a state-owned holding enterprise under the Guangzhou Pharmaceutical Holdings (GPHL) Group, specializing in API and pharmaceutical lipid excipients, health products, and technical services. With a global customer base of over 1,000 clients across more than 30 countries, the company operates a sole production base in Conghua, Guangzhou, and R&D centers in Haizhu, Guangzhou, and Hengqin, Zhuhai. It holds numerous national and international certifications and has received honors including the National May 1st Labor Award and National Green Factory .

The company’s mission is to achieve technological self-reliance, address "bottleneck" challenges, safeguard pharmaceutical industry chain security, inherit and innovate traditional Chinese medicine, and protect human health. For more information, visit http://byshanhanfang.com/ .

Contact Information

Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.

Copyright Copyright Notice:Baiyunshan Hanfang
Related Articles

Guess You Like